Cargando…

Adjuvanted influenza vaccine dynamics

Adjuvanted influenza vaccines constitute a key element towards inducing neutralizing antibody responses in populations with reduced responsiveness, such as infants and elderly subjects, as well as in devising antigen-sparing strategies. In particular, squalene-containing adjuvants have been observed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parra-Rojas, César, Messling, Veronika von, Hernandez-Vargas, Esteban A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329778/ https://www.ncbi.nlm.nih.gov/pubmed/30635599 http://dx.doi.org/10.1038/s41598-018-36426-9

Ejemplares similares

Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
por: Parra-Rojas, César, et al.
Publicado: (2018)

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
por: Demminger, Daniel E, et al.
Publicado: (2020)

NS1-mediated delay of immune activation contributes to influenza A virulence in ferrets
por: Meunier, I, et al.
Publicado: (2011)

Advances in Adjuvanted Influenza Vaccines
por: Shichinohe, Shintaro, et al.
Publicado: (2023)

Early cytokine mRNA expression profiles predict Morbillivirus disease outcome in ferrets
por: Svitek, Nicholas, et al.
Publicado: (2007)

A Novel Ribozyme-Based Prophylaxis Inhibits Influenza A Virus Replication and Protects from Severe Disease
por: Motard, Julie, et al.
Publicado: (2011)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9
por: Hörner, Cindy, et al.
Publicado: (2023)

Ferrets as a Model for Morbillivirus Pathogenesis, Complications, and Vaccines
por: Pillet, S., et al.
Publicado: (2009)

Avian Influenza A Virus Infects Swine Airway Epithelial Cells without Prior Adaptation
por: Shin, Dai-Lun, et al.
Publicado: (2020)

How respiratory viruses overcome mucosal defenses and exploit the unique environment of the respiratory tract
por: von Messling, Veronika Al, et al.
Publicado: (2012)

Food Additives as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019)

Near-Infrared Laser Adjuvant for Influenza Vaccine
por: Kashiwagi, Satoshi, et al.
Publicado: (2013)

Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus
por: da Fontoura Budaszewski, Renata, et al.
Publicado: (2016)

Injectable Excipients as Novel Influenza Vaccine Adjuvants
por: Feng, Huapeng, et al.
Publicado: (2019)

Promising Adjuvants and Platforms for Influenza Vaccine Development
por: Zhu, Wandi, et al.
Publicado: (2021)

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination
por: Karlsson, Erik A., et al.
Publicado: (2016)

Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications
por: Boikos, Constantina, et al.
Publicado: (2021)

Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity
por: Enkirch, Theresa, et al.
Publicado: (2019)

An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain
por: Ruiz-Aragón, Jesús, et al.
Publicado: (2023)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Riboflavin as a Mucosal Adjuvant for Nasal Influenza Vaccine
por: Yin, Yinyan, et al.
Publicado: (2021)

AS03- and MF59-Adjuvanted Influenza Vaccines in Children
por: Wilkins, Amanda L., et al.
Publicado: (2017)

Type I IFN Triggers RIG-I/TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected Cells
por: Pothlichet, Julien, et al.
Publicado: (2013)

GLA-AF, an Emulsion-Free Vaccine Adjuvant for Pandemic Influenza
por: Clegg, Christopher H., et al.
Publicado: (2014)

Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines
por: van Essen, Gerrit A, et al.
Publicado: (2014)

A micro-sterile inflammation array as an adjuvant for influenza vaccines
por: Ji, Wang, et al.
Publicado: (2014)

Morbillivirus and henipavirus attachment protein cytoplasmic domains differently affect protein expression, fusion support and particle assembly
por: Sawatsky, Bevan, et al.
Publicado: (2016)

The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
por: Kohli, Michele A., et al.
Publicado: (2021)

Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
por: Tsai, Theodore F
Publicado: (2013)

Elements in the Canine Distemper Virus M 3′ UTR Contribute to Control of Replication Efficiency and Virulence
por: Anderson, Danielle E., et al.
Publicado: (2012)

Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
por: Villa, Marco, et al.
Publicado: (2013)

Modelling the Economic Impact of lnfluenza Vaccine Programs with the Cell-Based Quadrivalent Influenza Vaccine and Adjuvanted Trivalent Influenza Vaccine in Canada
por: Nguyen, Van Hung, et al.
Publicado: (2022)

Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks
por: Liu, Chun G, et al.
Publicado: (2011)

Effectiveness of Adjuvanted Influenza Vaccination in Elderly Subjects in Northern Italy
por: Mannino, Salvatore, et al.
Publicado: (2012)

MF59(®)‐adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
por: Banzhoff, Angelika, et al.
Publicado: (2008)

Development of novel cationic microemulsion as parenteral adjuvant for influenza vaccine
por: Lamaisakul, Sakalanunt, et al.
Publicado: (2020)

Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
por: Qin, Tao, et al.
Publicado: (2020)

Evaluating α-galactosylceramide as an adjuvant for live attenuated influenza vaccines in pigs
por: Artiaga, Bianca L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p5tiin2vtj51m8uk1iio5j8b0r